Table 2.

Recommended reporting of clinical variables for future studies

Essential clinical characteristics

Age

Sex

Race

Previous COVID-19 infection (PCR-positive, or clear clinical features early in the pandemic when antigen testing was not widely available)

Previous immunosuppression

Diabetic status

Type of vaccine

Time after vaccination (recommended 28 days after vaccine doses)

Desired clinical characteristics

Primary cause of kidney disease

Prevaccination antibody status

Medical comorbidities

COVID-19, coronavirus disease 2019; PCR, polymerase chain reaction.